News for hackers. Stuff that matters.

A comment on NIH trial of remdesivir for COVID-19 begins in hospitalized adults in Nebraska. Parent comment

Re:NIH trial of remdesivir for COVID-19 begins in hospitaliz... by refurb on Thursday February 27, 2020 @01:58PM (#22436527)
What?

If the people who do the basic research patent their work, sure they get financially rewarded for it.

Go talk to the chemist at Northwestern who discovered Lyrica. Or the CF Foundation who made billions from Kalydeco.

[ Parent | on HN ]
Re:NIH trial of remdesivir for COVID-19 begins in hospitaliz... by dekhn on Thursday February 27, 2020 @02:20PM (#22436764)
It really depends on a lot of factors. Not every scientist who has their name on a patent that led to a billion dollar drug saw much money from it.

the university sees much of the upside.

[ Parent | on HN ]
Re:NIH trial of remdesivir for COVID-19 begins in hospitaliz... by refurb on Thursday February 27, 2020 @08:56PM (#22439898)
That’s true, it all depends on the agreement with the university.
[ Parent | on HN ]